التفاصيل البيبلوغرافية
| العنوان: |
Protective effects of baicalin on carbon tetrachloride induced liver injury by activating PPARγ and inhibiting TGFβ1. |
| المؤلفون: |
Qiao, Hongxiang, Han, Hongcan, Hong, Dongsheng, Ren, Zihua, Chen, Yan, Zhou, Changxin |
| المصدر: |
Pharmaceutical Biology; Jan2011, Vol. 49 Issue 1, p38-45, 8p |
| مصطلحات موضوعية: |
DRUG efficacy, CARBON tetrachloride, DRUG dosage, LIVER injuries, FIBROSIS, FLAVONOIDS, ENZYME-linked immunosorbent assay, TRANSFORMING growth factors-beta, PLANT cell microbodies, POLYMERASE chain reaction |
| مستخلص: |
Context: Traditional Chinese herbal medicines have attracted considerable attention in many countries with treatment of several end-stage liver diseases. Objective: The present study investigated the protective effects of baicalin on hepatotoxicity and hepatic fibrosis and explored the role of transforming growth factor β1 (TGFβ1) and peroxisome proliferator activated receptors γ (PPARγ) on the rat liver injury model. Materials and methods: The rat liver injury model was introduced by subcutaneous injection of carbon tetrachloride (CCl4) for 8 weeks. At week 5, rats were treated with baicalin of different doses or silymarin. Detection of biochemical indicators, histological analysis, and enzyme-linked immunosorbent assays were employed to evaluate severity of liver inflammation, and western blotting and RT-PCR assay were performed to evaluate TGFβ1 and PPARγ pathway related proteins and gene expression. Results: The administration of baicalin could significantly improve histological changes of CCl4 treated rat livers and return biochemical indicators for liver injury to nearly baseline level. In addition, the increased expression of TGFβ1 was markedly suppressed by baicalin, and decreased expression of PPARγ was also dramatically elevated by baicalin as well. The hepatoprotective effects of baicalin may be conferred by elevating the level of PPARγ contributing to down-regulation of TGFβ1 signaling pathway and suppression of hepatic stellate cell activation. Conclusions: The studies demonstrated that baicalin is a potent and promising antifibrotic drug in the treatment of hepatic fibrosis. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pharmaceutical Biology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
PDF full text from Publisher